Variation in Pediatric Palliative Care Allocation Among Critically Ill Children in the United States

Siobhán O'Keefe1, Aline B Maddux2, Kimberly S Bennett3

  • 1Department of Paediatric Critical Care, Children's Health Ireland at Temple Street, Dublin 1, Ireland.

Insights

Palliative care consult rates for critically ill children in the US remain low, despite increasing utilization. Significant institutional variation suggests potential inequities in access to this crucial care for vulnerable pediatric patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Palliative Care Research
  • Health Services Research

Background:

  • Critically ill children represent a vulnerable population with complex needs.
  • Palliative care aims to improve quality of life for patients with serious illnesses.
  • Understanding palliative care utilization in pediatric intensive care units (PICUs) is essential for optimizing care.

Purpose of the Study:

  • To estimate palliative care consultation rates and trends in critically ill children.
  • To characterize patient demographics and clinical factors associated with receiving palliative care.
  • To assess palliative care utilization in relation to established screening criteria.

Main Methods:

  • Retrospective cohort study utilizing data from 52 US children's hospitals (2007-2018).
  • Analysis of over 1 million hospitalizations in non-neonatal ICUs.
  • Mixed-effects multivariable modeling to identify factors associated with palliative care consultation.

Main Results:

  • Palliative care consultation was identified in 1.36% of hospitalizations.
  • Consultation was associated with older age, female sex, government insurance, in-hospital mortality, and meeting specific ICU or complex chronic condition criteria.
  • Palliative care utilization increased over time but showed significant institutional variation.

Conclusions:

  • Palliative care use among critically ill children in the US is low and increasing.
  • Substantial inter-institutional variability in palliative care allocation suggests potential inequities.
  • Further research is needed to understand factors driving these disparities and inform equitable access.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
151
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
128
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
124
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
132
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
101
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.7K